SCHEDULE 13G

Allogene Therapeutics Inc

Common Stock, par value $0.001 per share (the "Shares") · CUSIP: 019770106

Event date: 2025-07-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Citadel Advisors LLC

  Shares: 10,203,329.00 · Class: 4.7%

• Citadel Advisors Holdings LP

  Shares: 10,203,329.00 · Class: 4.7%

• Citadel GP LLC

  Shares: 10,203,329.00 · Class: 4.7%

• Citadel Securities LLC

  Shares: 3,142,822.00 · Class: 1.4%

• Citadel Securities Group LP

  Shares: 3,142,822.00 · Class: 1.4%

• Citadel Securities GP LLC

  Shares: 3,142,822.00 · Class: 1.4%

• Kenneth Griffin

  Shares: 13,346,151.00 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.